What's happening in clinical trials right now?

This episode shares updates from Dr Serge Geara, neurologist and mito fellow at NeuRA. He explained why mito is hard to treat and what new research is happening.Key points:New treatments like elamipretide, BIO101, KL133, REN001, NV354 and zagociguat are being studied.Research is early and still testing safety and effect.Biomarkers may help track mito in the future.The full recording, slides and written summary of this session are on our website:www.mito.org.au/resource/video/mito-community-summit-2025-whats-happening-in-clinical-trials-now/To stay connected, subscribe to the Mito Foundation Podcast. For support, call the Helpline on 1300 977 180 or visit mito.org.au.